Early Team Based Treatment For People With Psychotic Symptoms: The RAISE-Early Treatment Program Experience

Dr. Schooler’s work centers on the long-term course of schizophrenia and its treatment. She is especially interested in the first episode of psychosis, the relationship of psychological and pharmacological treatments and treatment adherence. Schizophrenia-related topics addressed by Dr. Schooler and her colleagues range from adherence to medication using cognitive behavioral therapy-based strategies, clinical trials of medications, long-term relapse prevention using injectable antipsychotic medications and the development of improved assessment instruments for symptoms and social functioning. Earlier in her 40-year career, she led multicenter trials of medication and psychosocial treatments for schizophrenia at the National Institute of Mental Health.

In addition to her studies at SUNY, she conducts research at the Georgetown University School of Medicine; the Veterans Affairs VISN 5 Mental Illness Research, Education and Clinical Center; and the Zucker Hillside Hospital of the North Shore-Long Island Jewish Health System.